Controversial influencer, Blessing Okoro, popularly known as Blessing CEO, has apologised to Nigerians following a wave of outrage over her controversial cancer claims, even as she maintained that her health condition was not fabricated.
The 36-year-old relationship blogger resurfaced on social media after weeks of silence, releasing a video in which she admitted that the saga had sparked confusion, public anger and embarrassment for her family.
She, however, insisted that her claims were genuine, promising to back them up with verifiable medical evidence.
The influencer pledged to make public her medical records, including scan results and biopsy reports, in a bid to clear doubts and rebuild public trust.
She also announced plans to document her health journey openly, assuring followers of full transparency going forward.
In a move seen as damage control, Blessing CEO offered to refund donations received from Nigerians who may feel misled by the controversy, urging them to provide proof of payment for reimbursement.
She expressed appreciation to supporters who contributed financially during the period, describing their gesture as invaluable despite the backlash trailing her claims.
The controversy erupted earlier this year after she announced that she was battling stage four cancer and solicited financial assistance from the public.
Doubts later emerged when a diagnostic centre, Xinus Medical Diagnostics, alleged that a medical report she shared had been altered and did not belong to her.
The situation escalated after a woman, Deborah Mbara, accused the influencer of using her medical records without consent, prompting her family to petition the Economic and Financial Crimes Commission over alleged fraud, forgery and cyberbullying.
Amid mounting pressure, the Nigerian Cancer Society also called for a thorough probe into the claims and the handling of public donations.
The unfolding scandal has continued to stir debate over accountability and transparency in online fundraising, with many Nigerians demanding stricter scrutiny of public appeals.